Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Lomitapide mesylate

Lomitapide mesylate

pharmaceutical raw materials
Lomitapide mesylate structure

Lomitapide mesylate 

structure
  • CAS No:

    202914-84-9

  • Formula:

    C39H37F6N3O2.xCH4O3S

  • Chemical Name:

    Lomitapide mesylate

  • Synonyms:

    9H-Fluorene-9-carboxamide,N-(2,2,2-trifluoroethyl)-9-[4-[4-[[[4′-(trifluoromethyl)[1,1′-biphenyl]-2-yl]carbonyl]amino]-1-piperidinyl]butyl]-,methanesulfonate (1:?);9H-Fluorene-9-carboxamide,N-(2,2,2-trifluoroethyl)-9-[4-[4-[[[4′-(trifluoromethyl)[1,1′-biphenyl]-2-yl]carbonyl]amino]-1-piperidinyl]butyl]-,methanesulfonate;BMS 201038 methanesulfonic acid salt;BMS 201038-04;Lomitapide mesylate;Juxtapid

Description

Lomitapide mesylate(AEGR-733; BMS-201038) is an inhibitor of microsomal triglyceride-transfer protein (MTP) wtih in vitro IC50 of 8 nM.IC50 value: 8 nM [1]Target: MTP inhibitorLomitapide is a small-molecule, microsomal triglyceride transfer protein (MTP) inhibitor, for the treatment of both familial and primary hypercholesterolemia. Oral, once-daily lomitapide will be targeted at patients resistant to HMG-CoA reductase inhibitors (statins) either due to abnormalities in liver function or


Lomitapide mesylate is a methanesulfonate (mesylate) salt prepared from equimolar amounts of lomitapide and methanesulfonic acid. Used as a complement to a low-fat diet and other lipid-lowering treatments in patients with homozygous familial hypercholesterolemia. It has a role as an anticholesteremic drug and a MTP inhibitor. It contains a lomitapide(1+).|Lomitapide Mesylate is a methanesulfonic acid form of lomitapide, a small molecule inhibitor of microsomal triglyceride transfer protein.

Lomitapide mesylate Basic Attributes

789.834

789.26700

X4S83CP54E

DTXSID60174170

C83892

Characteristics

124

9.68660

Safety Information

P201, P202, P273, P281, P308+P313, P405, P501

H351

|Danger|H351 (100%): Suspected of causing cancer [Warning Carcinogenicity]|P201, P202, P273, P281, P308+P313, P405, and P501|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Drug Information

AEGR 733

Lomitapide mesylate Use and Manufacturing

Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients

Computed Properties

Molecular Weight:789.8
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:12
Rotatable Bond Count:10
Exact Mass:789.26711156
Monoisotopic Mass:789.26711156
Topological Polar Surface Area:124
Heavy Atom Count:55
Complexity:1200
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Recommended Suppliers of Lomitapide mesylate

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.